References
- Desnick, R. J., Brady, R., Barranger, J., Collins, A. J., Germain, D. P., Goldman, M. G., Packman, S., Wilcox, W. R. and Grabowski, J. : Fabry disease, an under-recognized multisystemic disorder : expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann. Intern. Med. 138(4), 338 (2003) https://doi.org/10.7326/0003-4819-138-4-200302180-00014
- Barbey, F., Hayoz, D., Widmer, U. and Burnier, M. : Efficacy of enzyme replacement therapy in Fabry disease. Curr. Med. Chem. Cardiovasc. Hematol. Agents. 2(4), 277 (2004) https://doi.org/10.2174/1568016043356192
- Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E. and Desnick, R. J. : Safety and efficacy of recombinant human alpha-galactosidase A--replacement therapy in Fabry's disease. N. Engl. J. Med. 345(1), 9 (2001)
- Thurberg, B. L., Rennke, H., Colvin, R. B., Dikman, S., Gordon, R. E., Collins, A. B., Desnick, R. J. and O'Callaghan, M. : Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int. 62, 1933 (2002) https://doi.org/10.1046/j.1523-1755.62.s82.2.x
- Desnick, R. J., Brady, R., Barranger, J., Collins, A. J., Germain, D. P., Goldman, M., Grabowski, G., Packman, S. and Wilcox, W. R. : Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann. Int. Med. 138, 338 (2003) https://doi.org/10.7326/0003-4819-138-4-200302180-00014
- Frustaci, A., Chimenti, C., Ricci, R., Natale, L., Russo, M. A., Pieroni, M., Eng, C. M. and Desnick, R. J. : Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. N. Engl. J. Med. 345(1), 25 (2001)
- Schiffmann, R., Murray, G. J., Trec, D., Daniel, P., Sellos-Moura, M., Myers, M., Quirk, J. M., Zirzow, G. C., Borowski, M., Loveday, K., Anderson, T., Gillespie, F., Oliver, K. L., Jeffries, N. O., Doo, E., Liang, T. J., Kreps, Gunter, C. K., Frei, K., Crutchfield, K., Selden, R. F. and O'Brady, R. O. : Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc. Natl. Acad. Sci. 97, 365 (2000)
- Nelson, B. C., Roddy, T., Araghi, S., Wilkens, D., Thomas, J. J., Zhang, K., Sung, C. C. and Richards, S. M. : Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 805(1), 127 (2004) https://doi.org/10.1016/j.jchromb.2004.02.032
- Berna, L., Asfaw, B., Conzelmann, E., Cerny, B. and Ledvinova, J. : Determination of urinary sulfatides and other lipids by combination of reversed-phase and thin-layer chromatographies. Anal Biochem. 269(2), 304 (1999)
- Zeidner, K. M., Desnick, R. J. and Ioannou, Y. A. : Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit. Anal. Biochem. 267, 104 (1999)
- Schiffmann, R., Murray, G. J., Treco, D., Daniel, P., Sellos-Moura, M., Myers, M., Quirk, J. M., Zirzow, G. C., Borowski, M., Loveday, K., Anderson, T., Gillespie, F., Oliver, K. L., Jeffries, N. O., Doo, E., Liang, T. J., Kreps, C., Gunter, K., Frei, K., Crutchfield, K., Selden, R. F. and O'Brady, R. O. : Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc. Natl. Acad. Sci. 97, 365 (2000)
- Gross, S. K. and McCluer, R. H. : High-performance liquid chromatographic analysis of neutral glycosphingolipids as their per-O-benzoyl derivatives. Anal. Biochem. 102, 429 (1980)
- Ullman, M. D. and McCluer, R. : Quantitative microanalysis of perbenzoylated neutral glycosphingolipids by highperformance liquid chromatography with detection at 230 nm. J. Lipid Res. 19, 910 (1978)
- Lee, W. M. F., Westrick, M. A. and Macher, B. A. : Highperformance liquid chromatography of long-chain neutral glycosphingolipids and gangliosides. Biochim. Biophys. Acta. 712, 498 (1982)
- Strasberg, P. M., Warren, I., Skomorowski, M. A. and Lowden, J. A. : HPLC analysis of neutral glycolipids: an aid in the diagnosis of lysosomal storage disease. Clin. Chim. Acta. 132, 29 (1983)
- Yoo, H. H., Son, J. and Kim, D. H. : Liquid chromatographytandem mass spectrometric determination of ceramides and related lipid species in cellular extracts. J Chromatogr. B 843(2), 327 (2006) https://doi.org/10.1016/j.jchromb.2006.06.025
- Fauler, G., Rechberger, G. N., Devrnja, D., Erwa, W., Plecko, B., Kotanko, P., Breunig, F. and Paschke, E. : Rapid determination of urinary globotriaosylceramide isoform profiles by electrospray ionization mass spectrometry usingstearoyl-d35-globotriaosylceramide as internal standard. Rapid. Commun. Mass. Spectrom. 19(11), 1499 (2005) https://doi.org/10.1002/rcm.1948
- Boscaro, F., Pieraccini, G., la Marca, G., Bartolucci, G., Luceri, C., Luceri, F. and Moneti, G. : Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease. Rapid. Commun. Mass. Spectrom. 16(16), 1507 (2002)
- Nelson, B. C., Roddy, T., Araghi, S., Wilkens, D., Thomas, J. J., Zhang, K., Sung, C. C. and Richards, S. M. : Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 805(1), 127 (2004) https://doi.org/10.1016/j.jchromb.2004.02.032